Teresa C. Delgado

Teresa C. Delgado

Bizkaia Technology Park
Derio, PV, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications

Dietary Patterns in a Nationwide Cohort of Patients with Hereditary Fructose Intolerance.

Dietary Patterns in a Nationwide Cohort of Patients with Hereditary Fructose Intolerance.

Journal: Nutrients
Published: January 16, 2026

Hepatic HuR modulates glucose metabolism through the C/EBPβ/PCK1 pathway.

Hepatic HuR modulates glucose metabolism through the C/EBPβ/PCK1 pathway.

Journal: Molecular metabolism
Published: October 19, 2025

Lipidomics uncovers metabolic manifestations related to liver steatosis and low-grade systemic inflammation in diet-treated hereditary fructose intolerance patients.

Lipidomics uncovers metabolic manifestations related to liver steatosis and low-grade systemic inflammation in diet-treated hereditary fructose intolerance patients.

Journal: Clinical nutrition (Edinburgh, Scotland)
Published: October 16, 2025

NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1-NEDD8 pathway.

NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1-NEDD8 pathway.

Journal: Hepatology (Baltimore, Md.)
Published: April 03, 2025

Protocol for pull-down capture of ubiquitinated and NEDDylated liver proteins from transgenic biotinylated ubiquitin and NEDD8 mice.

Protocol for pull-down capture of ubiquitinated and NEDDylated liver proteins from transgenic biotinylated ubiquitin and NEDD8 mice.

Journal: STAR protocols
Published: November 15, 2024

Successful desensitization protocol to alglucosidase and avalglucosidase alfa in a patient with infantile-onset Pompe disease.

Successful desensitization protocol to alglucosidase and avalglucosidase alfa in a patient with infantile-onset Pompe disease.

Journal: Molecular genetics and metabolism reports
Published: October 05, 2024

Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potential.

Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potential.

Journal: Gut
Published: July 09, 2024

Modulatory effects of CNNM4 on protein- l -isoaspartyl- O -methyltransferase repair function during alcohol-induced hepatic damage.

Modulatory effects of CNNM4 on protein- l -isoaspartyl- O -methyltransferase repair function during alcohol-induced hepatic damage.

Journal: Hepatology (Baltimore, Md.)
Published: March 23, 2024

Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis.

Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis.

Journal: JHEP reports : innovation in hepatology
Published: March 19, 2024

Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells.

Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells.

Journal: Biomarker research
Published: March 12, 2024

The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis.

The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis.

Journal: Metabolism: clinical and experimental
Published: February 22, 2024

Neddylation inhibition prevents acetaminophen-induced liver damage by enhancing the anabolic cardiolipin pathway.

Neddylation inhibition prevents acetaminophen-induced liver damage by enhancing the anabolic cardiolipin pathway.

Journal: Cell reports. Medicine
Published: September 27, 2023
Showing 1-12 of 69

Last Updated: 09/26/2026